• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

NEWS

Autonomous Pedicle Screw Placement: Is Spine Robotics Ready for the Next Step?

May 13, 2026 By SPINEMarketGroup

Robotic guidance, navigation and planning are no longer experimental ideas in spine. They are already part of the market. Different systems follow different strategies, but the underlying message is the same: robotics has become part of how major spine companies want to compete. Still, most of what we call spine robotics today remains robotic assistance. The surgeon is still … [Read more...] about Autonomous Pedicle Screw Placement: Is Spine Robotics Ready for the Next Step?

Medtronic Hits a 52-Week Low: What Is the Market Seeing?

May 12, 2026 By SPINEMarketGroup

In recent weeks, much of the spine market discussion has focused on Globus Medical and the negative market reaction that followed otherwise strong operating results. But Globus is not alone. Medtronic, one of its most direct competitors in spine technology, has also been under pressure. Its stock recently hit a reported 52-week low at $77.15, and by May 11, 2026, was quoted … [Read more...] about Medtronic Hits a 52-Week Low: What Is the Market Seeing?

SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon

May 12, 2026 By SPINEMarketGroup

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, … [Read more...] about SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon

Cervical Fusion Implant Denials: Why Spine Societies Are Pushing Back

May 11, 2026 By SPINEMarketGroup

There are reimbursement disputes that affect only the margins of a market. Others say something more structural about the direction of the industry. The recent statement from leading U.S. spine surgery societies on cervical fusion implant denials belongs to the second category. The issue is not a new device seeking early coverage, nor an experimental technology asking for … [Read more...] about Cervical Fusion Implant Denials: Why Spine Societies Are Pushing Back

Globus Medical: Strong Q1, Weak Stock Reaction — Is the Market Asking for More?

May 9, 2026 By SPINEMarketGroup

Globus Medical’s latest results created an apparent contradiction. The company reported a very strong first quarter, raised its earnings guidance, continued to show the benefits of the NuVasive integration, and reinforced its position as one of the leading players in spine. Yet the stock did not move as many would have expected. In fact, the immediate market reaction was … [Read more...] about Globus Medical: Strong Q1, Weak Stock Reaction — Is the Market Asking for More?

Globus Medical: Stronger in Spine, but Could DePuy Synthes’ Trauma Business Be the Next Big Move?

May 8, 2026 By SPINEMarketGroup

Globus Medical’s first quarter 2026 results confirm something important: the company is no longer just digesting major acquisitions. It is beginning to show the operating logic behind them. The headline figures are strong, but the more relevant point is the quality of the performance. Growth came not only from Nevro, but also from the underlying business, particularly U.S. … [Read more...] about Globus Medical: Stronger in Spine, but Could DePuy Synthes’ Trauma Business Be the Next Big Move?

Globus Medical Reports First Quarter 2026 Results

May 7, 2026 By SPINEMarketGroup

AUDUBON, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the first quarter ended March 31, 2026. First Quarter 2026: “We’re off to a strong start in 2026 with 27% overall revenue growth and record first quarter earnings. Organic … [Read more...] about Globus Medical Reports First Quarter 2026 Results

Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants

May 7, 2026 By SPINEMarketGroup

CARLSBAD, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced the issuance of its fourth U.S. patent related to Aurora’s proprietary DEXA Technology® platform. The newly issued patent, U.S. Patent No. … [Read more...] about Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants

Carlsmed® Reports First Quarter 2026 Financial

May 6, 2026 By SPINEMarketGroup

First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported … [Read more...] about Carlsmed® Reports First Quarter 2026 Financial

ATEC Reports First Quarter Financial Results

May 5, 2026 By SPINEMarketGroup

CARLSBAD, Calif--(BUSINESS WIRE)-- Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2026, and business highlights. First Quarter 2026 Financial Results First Quarter … [Read more...] about ATEC Reports First Quarter Financial Results

SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating

May 5, 2026 By SPINEMarketGroup

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN Code: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, adaptive implants and … [Read more...] about SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating

Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

May 5, 2026 By SPINEMarketGroup

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2026, reflecting steady execution following recent spine commercial channel actions. Based on first-quarter performance, the Company reaffirmed its full-year 2026 financial guidance. All … [Read more...] about Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

Inhaled Corticosteroids and Lumbar Fusion: A New Revision Risk Signal?

May 4, 2026 By SPINEMarketGroup

A new study published in Global Spine Journal, carried out by researchers from Johns Hopkins together with collaborators from the All India Institute of Medical Sciences (AIIMS) in New Delhi, has put an unusual detail on the radar of spine surgeons: the long-term use of inhaled corticosteroids in asthma patients. At first sight, this may sound like a minor point. Inhaled … [Read more...] about Inhaled Corticosteroids and Lumbar Fusion: A New Revision Risk Signal?

Spineway : First-quarter 2026 revenue

May 2, 2026 By SPINEMarketGroup

First-quarter 2026 revenue Spineway, a specialist in innovative implants for the treatment of severe spine disorders, recorded revenue of €2.2 million in the first quarter of 2026. Following strong growth in the fourth quarter of 2025 (+38%), the slowdown observed in the first quarter of 2026 will not undermine the Group’s momentum. It is mainly attributable to delays … [Read more...] about Spineway : First-quarter 2026 revenue

Theradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion

May 1, 2026 By SPINEMarketGroup

FDA authorization marks critical milestone enabling advancement of next-generation bone regeneration therapy for patients with degenerative spinal diseases FREDERICK, Md., April 30, 2026 /PRNewswire/ -- Theradaptive, Inc., a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, today announced that the U.S. Food … [Read more...] about Theradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion

Demetra acquires Maxxspine Innovative GmbH, a company that has been a leader in advanced spinal solutions for over twenty years, further strengthening its position as a benchmark in spine surgery

April 30, 2026 By SPINEMarketGroup

MILAN, April 30, 2026 /PRNewswire/ -- Demetra, an innovative and independent international medical company leader providing bone cements, spacers and biomaterials for orthopedic, spine and neuro applications and orthopedic infection control, announces the successful completion of the acquisition of Maxxspine Innovative GmbH, a German-based company specialized in … [Read more...] about Demetra acquires Maxxspine Innovative GmbH, a company that has been a leader in advanced spinal solutions for over twenty years, further strengthening its position as a benchmark in spine surgery

VB Spine Announces VB Spine Solutions, a Partnership-Driven Program to Help Hospitals Acquire Technology

April 30, 2026 By SPINEMarketGroup

New partnership-driven approach expands access to spine technology NEW YORK--(BUSINESS WIRE)--VB Spine LLC (“VB Spine”), today launched VB Spine Solutions, a program designed to bring critical spine technology to hospitals faster, with structures built around patient need. While focused on spine, VB Spine Solutions aligns with hospitals to simplify how capital equipment … [Read more...] about VB Spine Announces VB Spine Solutions, a Partnership-Driven Program to Help Hospitals Acquire Technology

Taiwan’s Spine Industry: Why a Small Market Could Become a Serious Export Hub

April 29, 2026 By SPINEMarketGroup

The Taiwanese spine market is relatively small, it has a sophisticated healthcare system, broad access to care and strong medical infrastructure. However, reimbursement discipline and price pressure remain important realities. For spine companies, this creates a demanding environment: surgeons may be open to advanced technologies, but hospitals remain highly sensitive to cost, … [Read more...] about Taiwan’s Spine Industry: Why a Small Market Could Become a Serious Export Hub

Amnovis expands to the United States and acquires Westconn Precision Technologies’ additive manufacturing activities

April 29, 2026 By SPINEMarketGroup

Aarschot, Belgium - April 29, 2026--Amnovis, a Belgian additive manufacturing contract manufacturing organization serving regulated industries including medical devices, announces the establishment of a new operational entity in the United States and the acquisition of the additive manufacturing activities of Westconn Precision Technologies. Together, these steps represent a … [Read more...] about Amnovis expands to the United States and acquires Westconn Precision Technologies’ additive manufacturing activities

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 69
  • Go to Next Page »

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • BROCHURES
  • Globus Medical: Stronger in Spine, but Could DePuy…
  • PRODUCT LIBRARY
  • Who Is Really Winning the Mid-Tier Spine…
  • Globus Medical’s Strategy: Building a Closed-Loop…
  • Why Spine’s Commercial Model Needs a Reset? The real…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • What Is Medtronic’s PILAR™ Technique?
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • COMPANIES
  • Single-Use Spine Surgery Systems: The Future or…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • BoxSPINE Receives FDA Clearance for Rodless Spinal…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • Behind the Deal: The Strategic Logic of Zavation’s…
  • Orthofix Realigns Spine Leadership to Strengthen…
  • Johnson & Johnson Explores Potential $20B Sale…
  • VB Spine Announces Successful First Clinical Cases…
  • Expandable cages were adopted not because they fused…
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • From Early Innovations to Modern Practice: Where Are…
  • VB Spine Announces VB Spine Solutions, a…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • ATEC’s Valence: Robotics in Service of a Procedural Strategy
  • Globus Medical Reports First Quarter 2026 Results
  • +10 Anterior Buttress Plates to Know…! | Updated 2026
  • Autonomous Pedicle Screw Placement: Is Spine…
  • LAST 5 VIDEOS PUBLISHED

    1. ATEC Spine: SafeOp®
    2. REACH Medical: Expandable PLIF/TLIF Cage
    3. Expanding Innovations: X-PAC®TLIF 
    4. SI-BONE: iFuse INTRA Ti™ Implant System
    5. Globus Medical: IntraLIF™ Cannulated

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup